$8.8M
1 filing since 2024 · latest Equity filed
Simergent is an Oklahoma City medical technology company developing devices and digital health systems for people with kidney disease. Its automated peritoneal dialysis system, Archimedes, received FDA 510(k) clearance and is designed to let end-stage kidney disease patients dialyze at home or in a clinic without blood leaving the body. The company was founded in 2014 by Steve J. Lindo, a former lead system designer on Baxter Healthcare's automated peritoneal dialysis system. A U.S. launch of Archimedes is planned for 2026 following a human factors usability study affiliated with Northwestern University and Indiana University.
What sets it apart
An FDA-cleared automated peritoneal dialysis machine built for home use, with lower fill and drain pressures, patented features intended to reduce touch contamination and peritonitis risk, a roughly five-minute setup, a four-hour battery and a mobile cart that let patients move around the house during treatment.
An FDA 510(k)-cleared automated peritoneal dialysis (APD) system that delivers bloodless dialysis for end-stage kidney disease patients in the home or in a clinic.
